alexa Deep vein thrombosis | Poland| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences
  • 30th European Heart Diseases and Heart Failure Congress
    February 18-19, 2019 Amsterdam, Netherlands
  • Middle East Heart Congress
    March 18-20, 2019 Dubai, UAE
  • 5th World Heart Congress
    March 27- 28, 2019 Sydney, Australia
  • 2nd Global Cardiology Summit
    May 13-14, 2019 Perth, Australia
  • 31st Annual Cardiologists Conference
    June 17-19, 2019 Rome, Italy
  • European Cardiology Congress
    July 01-02, 2019 Prague, Czech Republic
  • 6th Global Experts Meeting on Cardiovascular Pharmacology
    July 12-13, 2019 Yokohama, Japan
  • 27th International Conference & Exhibition on Cardiology and Cardiovascular Medicine
    July 26-27, 2019 Kyoto, Japan
  • 27th International Congress on Cardiology and medical interventions
    July 31-August 01, 2019 Chicago, USA
  • 5th World Congress on Cardiology and Cardiovascular Therapeutics
    August 12-13, 2019 Tokyo, Japan
  • 7th World Heart Congress
    August 19- 20, 2019 Vienna, Austria
  • European Heart Congress
    October 23-24, 2019 Amsterdam, Netherlands
  • 32nd European Cardiology Conference
    October 24-26, 2019 Zurich, Switzerland

Deep Vein Thrombosis

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Deep vein thrombosis

    Pathophysiology

    Deep vein thrombosis, or deep venous thrombosis, (DVT) is the formation of a blood clot (thrombus) within a deep vein, predominantly in the legs. Non-specific signs may include pain, swelling, redness, warmness, and engorged superficial veins. DVT often develops in the calf veins and "grows" in the direction of venous flow, towards the heart. When DVT does not grow; it can be cleared naturally and dissolved into the blood (fibrinolysis).

    Disease Statistics: Postal self-administered questionnaires about VTE prophylactic methods practiced by Polish neurologists were sent to 218 neurological wards where stroke is treated. If no response was received, the questionnaire was faxed and finally we attempted to obtain information by telephone. One hundred and seventy-six (80.7%) stroke centers of 218 responded. The majority (137/176; 77.8%) of centers had a stroke unit. The median admission rate of surveyed wards was estimated to be 320 patients/year (range from 20 to 1000 patients/year). The most common method of VTE prophylaxis reported was low molecular weight heparin (LMWH) (98.9%), and the least common was intermittent pneumatic compression (IPC) (6.8%).

  • Deep vein thrombosis

    Treatment

    The basic treatments for the disease are Anticoagulation, which prevents further coagulation, home treatment, stockings, walking, and repeat imaging and IVC filters, thrombolysis, and thrombectomy. The aims of the physicians are to prevent clot becoming larger, clot becoming lose and traveling to lungs, new clot formation and Post thrombotic syndrome.

    Major Research on Disease

    The current major research on the diseases are efficacy of low doses of heparin for the prevention of the DVT after a major surgery, accuracy of the clinical assessment for DVT, Decreased plasma levels of activated factor VII in patients with deep vein thrombosis etc.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings